These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 29284679)

  • 21. AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models.
    Selles MC; Fortuna JTS; Cercato MC; Santos LE; Domett L; Bitencourt ALB; Carraro MF; Souza AS; Janickova H; Azevedo CV; Campos HC; de Souza JM; Alves-Leon S; Prado VF; Prado MAM; Epstein AL; Salvetti A; Longo BM; Arancio O; Klein WL; Sebollela A; De Felice FG; Jerusalinsky DA; Ferreira ST
    Mol Ther; 2023 Feb; 31(2):409-419. PubMed ID: 36369741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.
    Hu W; Feng Z; Xu J; Jiang Z; Feng M
    Brain Res; 2019 May; 1710():61-73. PubMed ID: 30586546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.
    Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G
    Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.
    DiChiara T; DiNunno N; Clark J; Bu RL; Cline EN; Rollins MG; Gong Y; Brody DL; Sligar SG; Velasco PT; Viola KL; Klein WL
    Yale J Biol Med; 2017 Mar; 90(1):45-61. PubMed ID: 28356893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ
    Li S; Hayden EY; Garcia VJ; Fuchs DT; Sheyn J; Daley DA; Rentsendorj A; Torbati T; Black KL; Rutishauser U; Teplow DB; Koronyo Y; Koronyo-Hamaoui M
    Front Immunol; 2020; 11():49. PubMed ID: 32082319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
    Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
    Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model.
    Cone AS; Yuan X; Sun L; Duke LC; Vreones MP; Carrier AN; Kenyon SM; Carver SR; Benthem SD; Stimmell AC; Moseley SC; Hike D; Grant SC; Wilber AA; Olcese JM; Meckes DG
    Theranostics; 2021; 11(17):8129-8142. PubMed ID: 34373732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers.
    Jürgensen S; Antonio LL; Mussi GE; Brito-Moreira J; Bomfim TR; De Felice FG; Garrido-Sanabria ER; Cavalheiro ÉA; Ferreira ST
    J Biol Chem; 2011 Feb; 286(5):3270-6. PubMed ID: 21115476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles from Mesenchymal Stem Cells Exert Pleiotropic Effects on Amyloid-β, Inflammation, and Regeneration: A Spark of Hope for Alzheimer's Disease from Tiny Structures?
    Elia CA; Losurdo M; Malosio ML; Coco S
    Bioessays; 2019 Apr; 41(4):e1800199. PubMed ID: 30919493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
    Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
    J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow-derived mesenchymal stem cells attenuate amyloid β-induced memory impairment and apoptosis by inhibiting neuronal cell death.
    Lee JK; Jin HK; Bae JS
    Curr Alzheimer Res; 2010 Sep; 7(6):540-8. PubMed ID: 20455866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
    Lee JK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxic Ca
    Núñez L; Calvo-Rodríguez M; Caballero E; García-Durillo M; Villalobos C
    Methods Mol Biol; 2018; 1779():341-354. PubMed ID: 29886542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral dopamine neurotrophic factor alleviates Aβ
    Zhou W; Chang L; Fang Y; Du Z; Li Y; Song Y; Hao F; Lv L; Wu Y
    Neurosci Lett; 2016 Oct; 633():40-46. PubMed ID: 27616705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sub-lethal levels of amyloid β-peptide oligomers decrease non-transferrin-bound iron uptake and do not potentiate iron toxicity in primary hippocampal neurons.
    SanMartín CD; Paula-Lima AC; Hidalgo C; Núñez MT
    Biometals; 2012 Aug; 25(4):805-13. PubMed ID: 22526560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt Signaling Prevents the Aβ Oligomer-Induced Mitochondrial Permeability Transition Pore Opening Preserving Mitochondrial Structure in Hippocampal Neurons.
    Arrázola MS; Ramos-Fernández E; Cisternas P; Ordenes D; Inestrosa NC
    PLoS One; 2017; 12(1):e0168840. PubMed ID: 28060833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons.
    Seixas da Silva GS; Melo HM; Lourenco MV; Lyra E Silva NM; de Carvalho MB; Alves-Leon SV; de Souza JM; Klein WL; da-Silva WS; Ferreira ST; De Felice FG
    J Biol Chem; 2017 May; 292(18):7395-7406. PubMed ID: 28302722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The n-terminal 5-MER peptide analogue P165 of amyloid precursor protein exerts protective effects on SH-SY5Y cells and rat hippocampus neuronal synapses.
    Wang P; Jiang S; Cui Y; Yue Z; Su C; Sun J; Sheng S; Tian J
    Neuroscience; 2011 Jan; 173():169-78. PubMed ID: 21055450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.